Renal service during the COVID-19 pandemic (Association of nephrologists position statement)
https://doi.org/10.36485/1561-6274-2021-25-1-9-17
Abstract
The editorial touches upon the problem of the possible impact of COVID-19 on CKD patients, mediated by the forced reorganization of the health care system in a whole, the redistribution of its resources in the context of the COVID-19 pandemic. Lack of regular outpatient monitoring, delayed diagnosis and therapy in patients with kidney dysfunction are factors of adverse clinical outcomes - accelerated disease progression, ESKD development and the need for KRT, life-threatening complications, reduced quality of life and survival. The data of a pooled analysis of the impact of the pandemic on specialized renal care and its availability in a number of regions of the Northwest Federal District of Russia and the Moscow Region are presented: a fall in hospital admissions, outpatient consultations and a decrease in the use of hospital beds (on average, by 37 %, 40 % and 32 %, respectively). Principles and conditions of the functioning of health systems associated in the COVID-19 pandemic have been discussed. The main approaches to maintaining the standard level of renal patients care have been formulated, aimed at preventing an unfavorable patient-oriented CKD outcomes.
About the Authors
V. A. DobronravovRussian Federation
Prof. Vladimir A. Dobronravov - MD, PhD, DSc, Deputy Director for Research, Department of Propedeutics of Internal Diseases with the Clinic, Professor.
197022, Saint Petersburg, L. Tolstoy st., 17, build. 54, Phone: +7(812)338-69-01
A. V. Vatazin
Russian Federation
Prof. Andrey V. Vatazin - MD, PhD, DMedSci, Postgraduate Medical Faculty, Department of transplantology, nephrology and artificial organs, Head.
129110, Moscow, Shchepkin st., 61/2, Phone: +7(495)684-54-53
A. V. Smirnov
Russian Federation
Prof. Alexey V. Smirnov - MD, PhD, DMedSci, Director, Department of Propedeutics of Internal Diseases with the Clinic, Head.
197022, Saint Petersburg, L. Tolstoy st., 17, build 54, Phone: +7(812)338-69-01
M. M. Batiushin
Russian Federation
Prof. Michail M. Batiushin - MD, PhD., DMedSci, professor, Nephrology clinic, head of clinic
344022, Rostov-on-Don, 29 Nakhichevansky Ln , Phone: +78632014423I. N. Bobkova
Russian Federation
Prof. Irina N.Bobkova - MD, PhD, DMedSci, Department of internal, occupational diseases and rheumatology.
119991, Moscow, Trubetskaya str.8, build. 2, Phone: (499) 2484166А. B. Zulkarnaev
Russian Federation
Alexey B. Zulkarnaev - MD, PhD, DMedSci, Associate Professor, Surgical Department of kidney transplantation.
129110, Moscow, 61/2-6, Shchepkina str., Phone: 8-916-705-98-99
E. V. Antonova
Russian Federation
Elizaveta V. Antonova – nephrologist.
197022, Saint Petersburg, L. Tolstoy st., 6-8, Phone: +7(812)429-03-31
S. Sh. Butrimova
Russian Federation
Svetlana Sh. Butrimova - Deputy Chief Physician at the Medical Unit.
173008, Veliky Novgorod, Pavla Levitta st., 14, Phone: +7(921)842-70-02, +7(921)842-70-03
M. V. Bush
Russian Federation
Marina V. Bush - Head of the Department of Nephrology No. 1.
197022, Saint Petersburg, L. Tolstoy st., 17, build. 54, Phone: +7(812)338-69-23
L. G. Zhukova
Russian Federation
Larisa G. Zhukova - Department of Nephrology and Hemodialysis, Head of Department.
180007, Pskov, Malyasova st., 2, Phone: +7(921)218-38-28
D. V. Politov
Russian Federation
Dmitry V. Politov - Department of Nephrology, Head of Department.
1834047, Murmansk, Akademika Pavlova st., 6, Phone: +7(8152)285-223
V. N. Stepanov
Russian Federation
Valentin N. Stepanov - Head of the hemodialysis department.
160013, Vologda, Lechebnaya st., 17, Phone: +7(8172)209-004, 209001E. V. Tkachenko
Russian Federation
Elena V. Tkachenko - Department of Nephrology, Head of Department.
194291, Saint Petersburg, Lunacharsko-go Ave., 45, k.2, liter A, Phone: +7(812)670-18-88
A. A. Shumilina
Russian Federation
Antonina A. Shumilina - Clinic of the Research Institute of Nephrology, Head of the Department of Nephrology No. 2.
197022, Saint Petersburg, L. Tolstoy st., 17, build. 54, Phone: +7(812)338-69-22
References
1. Li J, Huang DQ, Zou B et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J Med Virol 2020; 10.1002/jmv.26424. doi: 10.1002/jmv.26424
2. Wang B, Li R, Lu Z, Huang Y. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging 2020;12(7):6049-6057
3. Williamson EJ, Walker AJ, Bhaskaran K et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020;584(7821):430-436. doi: 10.1038/s41586-020-2521-4
4. Gansevoort RT, Hilbrands LB. CKD is a key risk factor for COVID-19 mortality. Nat Rev Nephrol 2020;16(12):705-706. doi: 10.1038/s41581-020-00349-4
5. Kant S, Menez SP, Hanouneh M et al. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol 2020;21(1):449. doi: 10.1186/s12882-020-02112-0
6. Zhou S, Xu J, Xue C et al. Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review. Ren Fail 2020;43(1):1-15. doi: 10.1080/0886022X.2020.1847724
7. Hansrivijit P, Qian C, Boonpheng B et al. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. J Investig Med 2020;68(7):1261-1270. doi: 10.1136/jim-2020-001407
8. International Society of Nephrology. COVID-19. RECOMMENDATIONS. https://www.theisn.org/initiatives/covid-19/recommendations/#covid-19-in-patients-with-chronic-kidney-disease
9. Shilov EM. On the work of the presidium of the profile commission. Clinical Nephrology 2020;12(3):4
10. Kotenko ON, Vinogradov VE, Dorofeeva EG et al. Organization of outpatient care for patients after organ transplantation during the pandemic of the new coronavirus infection COVID-19 in Moscow. Russian Journal of Transplantology and Artificial Organs 2020;22(S):174-175
11. Sharma V, Shaw A, Lowe M et al. The impact of the COVID-19 pandemic on renal transplantation in the UK. Clin Med (Lond) 2020;20(4):e82-e86. doi:10.7861/clinmed.2020-0183
12. World Health Organization. Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth 2009 (global observatory for eHealth series, Volume 2). Healthc Inform Res 2012;18(2):153-155. https://www.who.int/goe/publications/goe_telemedicine_2010.pdf
13. Smith AC, Thomas E, Snoswell CL et al. Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare 2020;26:309-313
14. Official information about the coronavirus in Russia. Documents of the RF Ministry of Health. https://стопкоронавирус.рф/info/ofdoc/who/ (In Russ.)
15. Ishani A, Christopher J, Palmer D et al. Telehealth by an interprofessional team in patients with ckd: a randomized controlled trial. Am J Kidney Dis 2016;68(1):41-49
16. Crowley ST, Belcher J, Choudhury D et al. Targeting access to kidney care via telehealth: the VA experience. Adv Chronic Kidney Dis 2017;24(1):22-30. doi :10.1053/j.ackd.2016.11.005
17. Venuthurupalli SK, Rolfe A, Fanning J et al. Chronic Kidney Disease, Queensland (CKD.QLD) registry: management of ckd with telenephrology. Kidney Int Reports 2018;3(6):1336-1343. doi: 10.1016/j.ekir.2018.07.013
18. Tan J, Mehrotra A, Nadkarni GN et al. Telenephrology: providing healthcare to remotely located patients with chronic kidney disease. Am J Nephrol 2018;47(3):200-207
19. Ladino MA, Wiley J, Schulman IH et al. Tele-nephrology: a feasible way to improve access to care for patients with kidney disease who reside in underserved areas. Telemed J E Health 2016;22(8):650-654
20. Predialysis observation. Chronic kidney disease. https://neph-roliga.ru/upload/iblock/2f3/CKF_11_Predialysis_neues%20CD%20(Russian_FINAL).pdf (In Russ.)
21. Malkina A, Tuot DS. Role of telehealth in renal replacement therapy education. Semin Dial 2018;31(2):129-134
22. Yates M, Watts RA, Bajema MI et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016;75(9):1583-1594
23. Floege J, Barbour SJ, Cattran DC et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019;95(2):268-280
24. Rovin BH, Caster DJ, Cattran DC et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019;95(2):281-295
25. ERA-EDTA Information for Nephrologists and other professionals on prevention and treatment of COVID-19 infections in kidney patients 2019. Patients with CKD using immunosuppressive therapy. https://www.era-edta.org/en/covid-19-news-and-information/
26. Temporary guidelines. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 9 (10/26/2020). http://www.rusnephrology.org/wp-content/up-loads/2020/10/%D0%9C%D0%A0_COVID-19_v.9.pdf (In Russ.)
Review
For citations:
Dobronravov V.A., Vatazin A.V., Smirnov A.V., Batiushin M.M., Bobkova I.N., Zulkarnaev А.B., Antonova E.V., Butrimova S.Sh., Bush M.V., Zhukova L.G., Politov D.V., Stepanov V.N., Tkachenko E.V., Shumilina A.A. Renal service during the COVID-19 pandemic (Association of nephrologists position statement). Nephrology (Saint-Petersburg). 2021;25(1):9-17. (In Russ.) https://doi.org/10.36485/1561-6274-2021-25-1-9-17